Home › NDC Lookup › RxCUI directory › RxCUI 749818

0.3 ML lanreotide 300 MG/ML Prefilled Syringe [Somatuline] — RxCUI 749818

Name: 0.3 ML lanreotide 300 MG/ML Prefilled Syringe [Somatuline] (RxCUI 749818)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 749818 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI749818

Official name0.3 ML lanreotide 300 MG/ML Prefilled Syringe [Somatuline]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as0.3 ML Somatuline 300 MG/ML Prefilled Syringe; Somatuline Depot 90 MG in 0.3 ML Prefilled Syringe; 0.3 ML Somatuline 300 MG/ML (as lanreotide acetate) Prefilled Syringe; Somatuline Depot 90 MG per 0.3 ML Prefilled Syringe

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)4,404 prescriptions · 37 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lanreotide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Lanreotide is used for three things: acromegaly (when your body makes too much growth hormone), certain neuroendocrine tumors of the gut and pancreas (called GEP-NETs), and carcino...
What conditions does lanreotide actually treat?
Lanreotide Injection is meant to be given by a healthcare provider — not self-injected at home. It goes as a deep injection under the skin in the upper outer area of your buttock,...
How is the injection given, and do I have to do it myself?

📖 Read our full Lanreotide Injection guide →

🕸️ Concept Web — How 0.3 ML lanreotide 300 MG/ML Prefilled Syringe [S... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.3 ML lanreotide 300 MG/ML Prefilled Syringe [Somatuline] RxCUI 749818 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Lanreotide 68092 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Somatuline 72664 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Lanreotide Prefilled Syringe 749806 SCDF
- Lanreotide Injectable Product 1162540 SCDG
- Lanreotide Prefilled Syringe [Somatuline] 749809 SBDF
- Somatuline Injectable Product 1185415 SBDG
- Prefilled Syringe 721656 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 0.3 ML lanreotide 300 MG/ML Prefilled Syringe 749817 SCD
- Lanreotide 300 MG/ML 731131 SCDC
- Lanreotide 300 MG/ML [Somatuline] 749812 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

0.3 ML lanreotide 300 MG/ML Prefilled Syringe SCD · 749817
Lanreotide 300 MG/ML SCDC · 731131
Lanreotide Prefilled Syringe SCDF · 749806
Lanreotide Injectable Product SCDG · 1162540

Brand-Name Concepts

Lanreotide 300 MG/ML [Somatuline] SBDC · 749812
Lanreotide Prefilled Syringe [Somatuline] SBDF · 749809
Somatuline Injectable Product SBDG · 1185415
Somatuline BN · 72664

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 749818 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
15054-1060-04	1 POUCH in 1 CARTON (15054-1060-4) / 1 SYRINGE in 1 POUCH /...	SOMATULINE DEPOT	Ipsen Biopharmaceuticals, Inc.	2019-09-01
15054-1090-04	1 POUCH in 1 CARTON (15054-1090-4) / 1 SYRINGE in 1 POUCH /...	SOMATULINE DEPOT	Ipsen Biopharmaceuticals, Inc.	2019-09-01
15054-1120-04	1 POUCH in 1 CARTON (15054-1120-4) / 1 SYRINGE in 1 POUCH /...	SOMATULINE DEPOT	Ipsen Biopharmaceuticals, Inc.	2019-09-01

Observed labelers: Ipsen Biopharmaceuticals, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1930	Lanreotide injection	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.